Cullinan Therapeutics, Inc. (CGEM) vs Teladoc Health, Inc. (TDOC)
A side-by-side comparison of Cullinan Therapeutics, Inc. and Teladoc Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGEM
Cullinan Therapeutics, Inc.
$16.25HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TDOC
Teladoc Health, Inc.
$5.77HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CGEM vs TDOC
growth of $100 · dividends reinvested · last 6yCGEM -46.4% (-9.9%/yr)TDOC -97.5% (-45.8%/yr)CGEM compounded faster over this window
Log scale — wide-divergence pair
CGEM TDOC
CGEM vs TDOC: by the numbers
- •TDOC is the larger company ($1.05B vs $999M market cap).
- •Both run net losses; CGEM's is the smaller (0.00% vs -7.13% net margin).
Metrics side by side
Valuation
| Metric | CGEM | TDOC |
|---|---|---|
| P/S ratio | N/A | 0.42 |
| P/B ratio | 3.10 | 0.80 |
| EV / EBITDA | N/A | 12.89 |
| FCF yield | N/A | 21.43% |
Profitability
| Metric | CGEM | TDOC |
|---|---|---|
| Gross margin | 0.00% | 73.53% |
| Operating margin | 0.00% | -6.98% |
| Net margin | 0.00% | -7.13% |
| ROE | -63.62% | -13.54% |
| ROIC | -68.64% | -7.32% |
Growth (annualized)
| Metric | CGEM | TDOC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 8.85% |
| Total return CAGR (5Y) | -7.48% | -45.85% |
Frequently asked
- How have CGEM and TDOC total returns compared?
- Over the past 5 years, CGEM delivered -7.48% and TDOC delivered -45.85% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cullinan Therapeutics ROETeladoc Health ROECullinan Therapeutics operating marginTeladoc Health operating marginCullinan Therapeutics revenue growthTeladoc Health revenue growthCullinan Therapeutics free cash flowTeladoc Health free cash flow
Cullinan Therapeutics & Teladoc Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.